N G Industries Ltd
Incorporated in 1994, N G Industries Ltd is in
the business of providing healthcare services[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of materials consumed (Medical Consumables/Pharmacy Items) INR Lakhs ・Standalone data |
|
|||||||||||
| Number of Medical Facilities (Divisions) Number ・Standalone data |
||||||||||||
| Number of permanent employees Number ・Standalone data |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Consideration And Approval Of 1. Audited Financial Results Of The Company For The Quarter And Year Ended 31St March, 2026 And 2. Dividend For The Financial Year Ended 31St March, 2026 Subject To Approval Of The Shareholders At The Ensuing AGM.
18 May - Board to meet on 28 May 2026 to approve audited FY26 results and final dividend.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 8 May
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
18 Apr - N G Industries states it is not a Large Corporate under SEBI debt rules.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 11 Apr
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
NGIL is in the healthcare business which
includes Doctor Clinics, Outpatient Services,
Diagnostic Laboratory and other Diagnostic Services, an Indoor Facility with wards and
ICU, Surgical Infrastructure, Dialysis Services, Special Clinics like Infertility, Retail Pharmacy,
Home Care Services, and an Adult Vaccination Unit